(b)(4).Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, weight, bmi at the time of index procedure the diagnosis and indication for the index surgical procedure? in what tissue layer was the suture used? what was the tissue condition pre-op, i.E., normal or thin, calcified, fragile, diseased? what was the tissue condition post-op, i.E., normal or thin, calcified, fragile, diseased? what were the current symptoms following the index surgical procedure? onset date? please clarify and describe what is meant by ¿two ears peel off¿? was medical intervention provided for the report of ¿two ears peel off¿? if yes, please describe.What was the appearance of the suture during reoperation on october 3, 2019? are patient photos available? other relevant patient history/concomitant medications product code and lot # if applicable, will the product be returned, return date, tracking information what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient¿s current status? events reported via mw 2210968-2019-89317.
|
Product complaint #: (b)(4).Date sent to the fda: 02/13/2020.Additional information: d10, h6.Additional h3 device evaluation summary: three suture pieces of product code z442h was received for analysis.During the visual inspection of the used suture pieces, body fluids and tissue were noted.The product code z442h is absorbable suture and at the time of the second surgery, the suture was on 103 days of the implantation at this time the suture was found absorbed according to the percentage of the original strength, the pds ii clear device is completely absorbed by 182 days post implantation.The manufacturing records could not be reviewed as the batch number is unknown.According to the sample condition, the cause could not be determined.
|